Veraxa Biotech's total assets for Q1 2026 were $272.28M, an increase of 0.82% from the previous quarter. VRXA total liabilities were $286.73M for the fiscal quarter, a 2049.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
